• 1
    Weizman AV, Ahn E, Thanabalan R, Leung W, Croitoru K, Silverberg MS, et al. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. Aliment Pharmacol Ther 2012; 35: 3429.
  • 2
    Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and meta-analysis. Integr Cancer Ther 2011; doi: 10.1177/1534735411423920[in press].
  • 3
    Knoeller GE, Mazurek JM, Moorman JE. Complementary and alternative medicine use among adults with work-related and non-work-related asthma. J Asthma 2011; doi:10.3109/02770903.2011.637597[in press].
  • 4
    Ernst E, Posadzki P. Complementary and alternative medicine for rheumatoid arthritis and osteoarthritis: an overview of systematic reviews. Curr Pain Headache Rep 2011; 15: 4317.
  • 5
    Nowack R, Birck R. Complementary and alternative medicine is popular among chronic renal failure patients – renal teams must increase their competence to advise patients with respect to efficacy and safety. Evid Based Nurs 2012; 15: 2930.
  • 6
    Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis 2010; 4: 63101.
  • 7
    Langmead L, Rampton DS. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther 2006; 23: 3419.
  • 8
    Fukunaga K, Hida N, Ohda Y, Takeda N, Iimuro M, Yoshida K, et al. A prospective randomised double blind placebo controlled trial to assess the efficacy of a Chinese herbal medicine “Xilei San” as remission induction and maintenance therapy in patients with refractory ulcerative proctitis. Gastroenterology 2011; 140: S261.